Oncology Market Intelligence & Decision Sciences Intern jobs in United States
cer-icon
Apply on Employer Site
company-logo

Corcept Therapeutics · 7 hours ago

Oncology Market Intelligence & Decision Sciences Intern

Corcept Therapeutics is a leading company in the research and development of cortisol modulators, focused on advancing treatments for serious diseases. The intern will support the Oncology Market Intelligence & Decision Sciences team by generating commercial insights and collaborating with cross-functional partners to guide decision-making across the oncology portfolio.

BiotechnologyMedicalPharmaceutical
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Generate and deliver actionable insights related to launch performance by analyzing early uptake dynamics, identifying barriers and drivers and providing clarity on emerging trends to guide ongoing launch activities
Contribute to a variety of cross-functional projects across the MINDS team, supporting forecasting, market research, competitive intelligence and analytics initiatives while integrating data-driven insights from primary and secondary sources to shape brand strategies
Deliver a department presentation at the end of the program
Participate as a member of the 2026 intern team group project that includes a company-wide presentation

Qualification

Analytical skillsExcelPowerPointMarket researchForecasting methodologiesOncologyExperience in drug/biotechCommunication skillsPresentation skillsInterpersonal skills

Required

Strong analytical skills with ability to synthesize large amounts of data and generate meaningful insights
Excellent communication, presentation and interpersonal skills with ability to distil complex insights into simple messages
Experience with Excel, PowerPoint, analytics tools, etc
This is a full-time internship (40 hours per week). Must be able to complete at least 10 consecutive weeks between June and August
Must be able to work at our Redwood City office for the duration of the internship, no relocation available
Bachelor's degree required
Applicants must be currently authorized to work in the United States on a full-time basis

Preferred

advanced degree (MBA, MS or PhD) preferred
Prior experience in the drug/biotech industry and knowledge of oncology landscape preferred
Knowledge of pharma market research, analytics and forecasting methodologies preferred

Company

Corcept Therapeutics

twittertwittertwitter
company-logo
Corcept Therapeutics discovers and develops drugs that regulate the effects of cortisol.

Funding

Current Stage
Public Company
Total Funding
$119.09M
Key Investors
Paperboy Ventures
2012-07-02IPO
2012-04-10Post Ipo Equity· $0.53M
2011-01-21Post Ipo Equity· $39M

Leadership Team

leader-logo
Roberto Vieira
President, Oncology
linkedin
leader-logo
Yuan Xu
Associate Director, Statistical Programming
linkedin
Company data provided by crunchbase